Table 1 Thromboembolic complications with COVID 19 disease reported in single/multicenter studies
From: Thromboembolic disease in COVID-19 patients: A brief narrative review
Author | Country | Venous thromboembolism - (%) | Pulmonary embolism percentage % or N | Arterial thromboembolism percentage (%) | Stroke percentage (%) | Acute coronary syndrome percentage (%) | Mesenteric/bowel Ischemia percentage (%) | Limb Ischemia percentage (%) |
|---|---|---|---|---|---|---|---|---|
Lodigiani et al [21] | Italy | 4.4 | 2.8 | 2.5 | 1.1 | |||
Middeldorp et al [22] | Netherlands | 20 | 6.6 | |||||
Helms et al [5] | France | 16.7 | 0.7 | 0.66 | ||||
Llitjos [6] | Italy | 69 | 23 | |||||
Marone [23] | Italy | 53 | ||||||
Wichmann et al [24] | Germany | 53 | 33 | |||||
Cui et al [25] | China | 25 | ||||||
Klok et al [7] | Netherlands | 27 49 | 13.5 87 | 3.7 | ||||
Dolhnikoff et al [20] | Brazil | 80 (Autopsy finding) | ||||||
Ackermann et al [26] | Germany | 57 Microthrombi without luminal occlusion | ||||||
Demelo-Rodriguez et al [27] | Spain | 14.7 | ||||||
Zhang et al [28] | China | 46.1 | ||||||
Ren at al [29] | China | 85.4 | ||||||
Stoneham et al [30] | UK | 7.7 | ||||||
Voicu et al [31] | France | 46 | ||||||
Desborough et al [32] | UK | 15 | 8 | |||||
Al-Samkari et al [33] | USA | 6 | N=10 | 2.8 | ||||
Fraisse et al [34] | France | 31.6 | 8.4 |